细胞生物资料
INTERNATIONAL JOURNAL OF ONCOLOGY 34: 1491-1503, 2009
Cancer stem cells - from initiation to elimination,
how far have we reached? (Review)
KAMAL AKHTAR, WENDY BUSSEN andSHAUN P. SCOTT
Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63108, USA
Received January 12, 2009; Accepted February 23, 2009
DOI: 10.3892/ijo_00000278
Abstract.Cancer stem cells (CSCs) are rare tumor cells thathave the potential to proliferate, self-renew and inducetumorigenesis. Over the past few years, CSCs have beenisolated from several different tumors and when implantedinto immune-deficient mice, generate tumors that are identicalto the parental tumors. In this review, we summarize thecurrent literature on CSCs, which suggests that since thesecells have the ability to drive tumor formation, specificallytargeting them may lead to more effective therapies againsttumors.
1.Introduction
Despite many advances in the early detection and treatmentof cancers, patient mortality rates remain high. This is due inpart to the survival of chemo- and radio-resistant cancer stemcells following treatment. Cancer stem cells (CSCs) aredefined as cells within a tumor that possess the capacity toself-renew and differentiate into the heterogeneous lineages

of cancer cells that comprise the tumor. Like ordinary cells,CSCs appear to be quiescent for much of their life, dividingon occasion to give rise to two daughter cells, either tworeplicas of itself (stem cell) or one stem cell and the other amore differentiated progenitor cell capable of furtherdifferentiation when given the appropriate signals. CSCsdrive tumorigenesis and give rise to a large population ofdifferentiated progeny that make up the bulk of the tumor andlack tumorigenic potential. While isolation of CSCs has onlyrecently occurred (see below), the concept of CSCs has beenaround for >40 years. Decades ago, cancer researchers notedthat tumors are composed of multiple cell types that appear tohave originated from a common ancestor cell and that whilechemotherapy and radiation treatment may eradicate a tumor,the cancer can re-grow and metastasize (1). These observationslead to the conclusion that a small subset of cells in a tumorhas the ability to sustain and re-create the tumor, althoughmany uncertainties still remain. It is becoming evident thatCSCs are the only cells in malignancy which have the abilityto expand, promote tumor growth as well as metastasize.Despite several studies which question the existence of suchcells (2,3), two general assumptions in the field of CSCbiology are that treatments which fail to eliminate CSCs mayallow re-growth of the tumor and specifically targeting CSCsmay cure cancers. Identification and characterization of CSCsmay lead to important advances in our understanding of cancerbiology and pave the way for the development of drugs thatspecifically target CSCs.

2.Discovery of cancer stem cells in multiple cancers

The first conclusive evidence for the existence of CSCs was

published in 1997 by Bonnet and Dick who studied acutemyelogenous leukemia (AML) (4). They isolated cells from apatient with AML and found that only a subset of the totalcells, termed SCID leukemia-initiating cells (SL-ICs), werecapable of initiating leukemia after transplantation into anon-obese diabetic, severe combined immunodeficient(NOD/SCID) mouse. SL-ICs carried the unique cell surface
Contents1.2.3.4.5.6.7.
Introduction
Discovery of cancer stem cells in multiple cancersSignaling pathways in cancer stem cellsOrigin of cancer stem cells
Mechanism of cancer stem cells
On the way to eliminate cancer stem cellsSummary and future prospects
_________________________________________
Correspondence to:Dr Shaun P. Scott, Department of Radiation
Oncology, Washington University School of Medicine, St. Louis,MO 63108, USA
E-mail: sscott@radonc.wustl.edu
Abbreviations: CSCs, cancer stem cells; NOD-SCID, non-obese
diabetic, severe combined immunodeficient; CC-ICs, colon cancerinitiating cells; BTSCs, brain tumor stem cells; HSCs, haematopoiticstem cells; AML, acute myelogenous leukemia; SL-IC, SCIDleukemia-initiating cells; SP, side population; BASCs, bronchio-alveolar stem cells; MIS, Mullerian inhibiting substance; DBH,debromohymenialdisin; HNSCC, head and neck squamous cellcarcinoma; BTICs, brain tumor initiating cells; NSP, non-sidepopulation; CML, chronic myelogenous leukemia; LSCs, leukemicstem cells; BCC, basal cell carcinoma; T-ALL, T-cell acutelymphoblastic leukemias
Key words:cancer stem cells, solid tumors, tumor initiation and
progression, metastasis, cancer stem cell marker, tumor therapy,leukemia, self-renewal
2010 Int J Oncol Cancer ... 13页 免费...Elimination of Human Lung Cancer Stem Cells ...initiation and tumor regeneration after chemotherapy....
Stem cells, cancer, an... 7页 2下载券 ...elimination of the TEM cells, exhibiting a marked...Oncol Rep, 2005. 14(2): p. Ribatti, D., ...
Int J Oncol. 2008 Jul;33(1):103-11. 2. ...Cajanol, a novel anticancer agent from Pigeonpea ...humanamniotic mesenchymal stem cells-laden ...
J Cancer Res Clin Oncol (2005) DOI 10.1007/s... successful isolating cancerous stem cells from ...Int J Cancer 36:299–306 Benchaouir R, Rameau ...
Transl Oncol 3(3):149-52, 2010 结肠癌细胞 27... initiation and metastasis in pancreatic cancer. ...Isolation of stem cells from human pancreatic ...
The elimination of Myc has been regarded as a ...stem cells (Trosko, 2006) and bladder cancer (...Int J Oncol 24, 257-263. Liu, S. V. (...
Int J Oncol Vol30 No3 Pg... 暂无评价 5页...Cancer and Inflammation Research, School of Chinese...elimination of damaged cells that have undergone ...
and initiation of vessel sprouting (Armulik et ...Selective Elimination of G-Pericytes Disrupts Tumor...(2012). Cancer stem cells: impact, heterogeneity...
2010 Int J Oncol Cancer ... 13页 免费 Autophagic pathways as n... ...stem cells Ethically OK: The stem cells came from cord blood rather than ...
A small number of cells in tumor play stem ...Int J Cancer, 2007, 120 1 2 3 Reya T, ...J Cancer Res Clin Oncol, 2008, 134(11): 1155...
热门文档